Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 3/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.42 |
| ▸ | PDE5A | O76074 | 2/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18256653 | 0.97 | KMT2A (0.51) | KMT2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL18256621 | 0.86 | ADORA2B (0.60) | ADORA2BRXFP1PDE4APDE4BPDE4C | |
| SCHEMBL20205963 | 0.86 | KMT2A (0.42) | KMT2AADORA2BRXFP1PDE4APDE4B | |
| SCHEMBL17682304 | 0.84 | KMT2A (0.54) | KMT2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL20182588 | 0.82 | KMT2A (0.47) | KMT2AADORA2BRXFP1TRPA1SMN1; SMN2 | |
| SCHEMBL18819581 | 0.82 | KMT2A (0.50) | KMT2AADORA2BRXFP1PDE4ATRPA1 | |
| SCHEMBL18256137 | 0.81 | KMT2A (0.66) | KMT2AADORA2BRXFP1SMN1; SMN2POLB | |
| SCHEMBL18819083 | 0.80 | KMT2A (0.48) | KMT2AADORA2BRXFP1PDE4APDE4B | |
| SCHEMBL18256065 | 0.80 | KMT2A (0.64) | KMT2AADORA2BRXFP1SMN1; SMN2MAPT | |
| SCHEMBL18819714 | 0.80 | ADORA2B (0.59) | ADORA2BRXFP1PDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180148451-A1 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | Guangdong Raynovent Biotech Co., Ltd. (CN) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180148451-A1 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | PNP, PDE7A, PDE2A | KMT2A 3573/4885ADORA2B 93/4885RXFP1 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.